Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:793-799

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peppel, K.
Right arrow Articles by Freedman, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peppel, K.
Right arrow Articles by Freedman, N. J.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Growth factors/cytokines
Right arrow Smooth muscle proliferation and differentiation
Right arrow Gene therapy

(Circulation. 2000;102:793.)
© 2000 American Heart Association, Inc.


Basic Science Reports

Overexpression of G Protein–Coupled Receptor Kinase-2 in Smooth Muscle Cells Attenuates Mitogenic Signaling via G Protein–Coupled and Platelet-Derived Growth Factor Receptors

Karsten Peppel, PhD; Anne Jacobson, BA; Xuewei Huang, BS; John P. Murray, BS; Martin Oppermann, MD; Neil J. Freedman, MD

From the Department of Medicine (Cardiology), Duke University Medical Center, Durham, NC, and the Department of Immunology, Universitätskliniken, Göttingen, Germany (M.O.).

Correspondence to Neil J. Freedman, MD, Box 3187, Duke University Medical Center, Durham, NC 27710. E-mail neil.freedman{at}duke.edu

Background—Neointimal hyperplasia involves activation of smooth muscle cells (SMCs) by several G protein–coupled receptor (GPCR) agonists, including endothelin-1, angiotensin II, thrombin, and thromboxane A2. Signaling of many GPCRs is diminished by GPCR kinase-2 (GRK2). We therefore tested whether overexpression of GRK2 in SMCs could diminish mitogenic signaling elicited by agonists implicated in the pathogenesis of neointimal hyperplasia.

Methods and Results—Overexpression of GRK2 was achieved in primary rabbit aortic SMCs with a recombinant adenovirus. Control SMCs were infected with an empty vector adenovirus. Inositol phosphate responses to endothelin-1, angiotensin II, thrombin agonist peptide, and platelet-derived growth factor (PDGF) were attenuated by 37% to 72% in GRK2-overexpressing cells (P<0.01), but the response to the thromboxane A2 analogue U46619 was unaffected. GRK2 also inhibited SMC [3H]thymidine incorporation stimulated not only by these agonists (by 30% to 60%, P<0.01) but also by 10% FBS (by 35%, P<0.05). However, GRK2 overexpression had no effect on epidermal growth factor–induced [3H]thymidine incorporation. Agonist-induced tyrosine phosphorylation of the PDGF-ß receptor, but not the epidermal growth factor receptor, was reduced in GRK2-overexpressing SMCs. GRK2 overexpression also reduced SMC proliferation in response to endothelin-1, PDGF, and 10% FBS by 62%, 51%, and 29%, respectively (P<0.01), without any effect on SMC apoptosis.

Conclusions—GRK2 overexpression diminishes SMC mitogenic signaling and proliferation stimulated by PDGF or agonists for several GPCRs. Gene transfer of GRK2 may therefore be therapeutically useful for neointimal hyperplasia.


Key Words: muscle, smooth • cells • signal transduction • receptors




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. E. Morris, C. P. Nelson, N. B. Standen, R.A. J. Challiss, and J. M. Willets
Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2
Cardiovasc Res, October 6, 2009; (2009) cvp310v2.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. M. Harris, H. I. Cohn, S. Pesant, R.-H. Zhou, and A. D. Eckhart
Vascular smooth muscle Gq signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3072 - H3079.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. E. Vinge, K. W. Andressen, T. Attramadal, G. O. Andersen, M. S. Ahmed, K. Peppel, W. J. Koch, N. J. Freedman, F. O. Levy, T. Skomedal, et al.
Substrate Specificities of G Protein-Coupled Receptor Kinase-2 and -3 at Cardiac Myocyte Receptors Provide Basis for Distinct Roles in Regulation of Myocardial Function
Mol. Pharmacol., September 1, 2007; 72(3): 582 - 591.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Wu, R. Goswami, X. Cai, S. T. Exum, X. Huang, L. Zhang, L. Brian, R. T. Premont, K. Peppel, and N. J. Freedman
Regulation of the Platelet-derived Growth Factor Receptor-beta by G Protein-coupled Receptor Kinase-5 in Vascular Smooth Muscle Cells Involves the Phosphatase Shp2
J. Biol. Chem., December 8, 2006; 281(49): 37758 - 37772.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-H. Wu, R. Goswami, L. K. Kim, W. E. Miller, K. Peppel, and N. J. Freedman
The Platelet-derived Growth Factor Receptor-{beta} Phosphorylates and Activates G Protein-coupled Receptor Kinase-2: A MECHANISM FOR FEEDBACK INHIBITION
J. Biol. Chem., September 2, 2005; 280(35): 31027 - 31035.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Peppel, L. Zhang, E. S. Orman, P.-O. Hagen, A. Amalfitano, L. Brian, and N. J. Freedman
Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms
Cardiovasc Res, February 15, 2005; 65(3): 674 - 682.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Zhang, K. Peppel, L. Brian, L. Chien, and N. J. Freedman
Vein Graft Neointimal Hyperplasia Is Exacerbated by Tumor Necrosis Factor Receptor-1 Signaling in Graft-Intrinsic Cells
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2277 - 2283.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. L. Hildreth, J.-H. Wu, L. S. Barak, S. T. Exum, L. K. Kim, K. Peppel, and N. J. Freedman
Phosphorylation of the Platelet-derived Growth Factor Receptor-{beta} by G Protein-coupled Receptor Kinase-2 Reduces Receptor Signaling and Interaction with the Na+/H+ Exchanger Regulatory Factor
J. Biol. Chem., October 1, 2004; 279(40): 41775 - 41782.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Zhang, N. J. Freedman, L. Brian, and K. Peppel
Graft-Extrinsic Cells Predominate in Vein Graft Arterialization
Arterioscler Thromb Vasc Biol, March 1, 2004; 24(3): 470 - 476.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. L. Bookout, A. E. Finney, R. Guo, K. Peppel, W. J. Koch, and Y. Daaka
Targeting G{beta}{gamma} Signaling to Inhibit Prostate Tumor Formation and Growth
J. Biol. Chem., September 26, 2003; 278(39): 37569 - 37573.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. J. Freedman, L. K. Kim, J. P. Murray, S. T. Exum, L. Brian, J.-H. Wu, and K. Peppel
Phosphorylation of the Platelet-derived Growth Factor Receptor-beta and Epidermal Growth Factor Receptor by G Protein-coupled Receptor Kinase-2. MECHANISMS FOR SELECTIVITY OF DESENSITIZATION
J. Biol. Chem., December 6, 2002; 277(50): 48261 - 48269.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Patterson, G. A. Stouffer, N. Madamanchi, and M. S. Runge
New Tricks for Old Dogs : Nonthrombotic Effects of Thrombin in Vessel Wall Biology
Circ. Res., May 25, 2001; 88(10): 987 - 997.
[Abstract] [Full Text] [PDF]